Taylor to head FDA field operations
This article was originally published in The Tan Sheet
Executive Summary
John Taylor appointed FDA senior associate commissioner for regulatory affairs, effective Sept. 5, replacing Dennis Baker. Promotion marks elevation of agency's top field operations job to senior associate commissioner rank, perhaps reflecting a move toward tighter controls on field offices. An attorney and 11-year FDA veteran, Taylor most recently served as ORA Office of Enforcement director. Last year, he testified on agency's dietary supplement enforcement authority under DSHEA at Senate hearing (1"The Tan Sheet" Sept. 17, 2001, p. 10). Baker, who championed restrictions on ephedrine while bureau chief of the Texas Dept. of Health Bureau of Food & Drug Safety, will aid commissioner's office in transition and advise on counter-terror activities until he succeeds retiring Dallas Regional Office Director Gary Pierce...
You may also be interested in...
DSHEA Enforcement Authority Questioned By Sen. Breaux At Hearing
Concerns that current law hampers government enforcement action against fraudulent dietary supplements surfaced again at a Senate Special Committee on Aging hearing Sept. 10.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.